Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres
- 15 September 1991
- Vol. 68 (6), 1272-1278
- https://doi.org/10.1002/1097-0142(19910915)68:6<1272::aid-cncr2820680616>3.0.co;2-l
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The duke afm program intensive induction chemotherapy for metastatic breast cancerCancer, 1990
- Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cellsInternational Journal of Cancer, 1989
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988
- Low Antigen Density Tumor Cells: An Obstacle to Effective Autologous Bone Marrow Purging?Cancer Investigation, 1987
- Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cellsBlood, 1987
- Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complementBlood, 1985
- EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASEThe Lancet, 1984
- Absence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2JNCI Journal of the National Cancer Institute, 1977
- Human Tumor Cells in VitroPublished by Springer Nature ,1975
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973